AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
ChemopreventionAnticarcinogenic AgentsSelective Estrogen Receptor ModulatorsRaloxifeneTamoxifenBreast NeoplasmsBreastNeoplasmsCarcinoma, Ductal, BreastCell Line, TumorAntineoplastic AgentsSulindacReceptors, EstrogenTumor Markers, BiologicalGene Expression Regulation, NeoplasticIsothiocyanatesFamily PracticeReceptor, erbB-2Breast DiseasesPrecancerous ConditionsClinical Trials as TopicPractice Guidelines as TopicRisk FactorsProstatic NeoplasmsCurcuminReceptors, ProgesteroneMammographyLung NeoplasmsAnti-Inflammatory Agents, Non-SteroidalMammary Neoplasms, ExperimentalColonic NeoplasmsApoptosisPrognosisCell ProliferationCyclooxygenase 2 InhibitorsNeoplasm InvasivenessNeoplasm MetastasisSilymarinCarcinogensCatechinPhysician's Practice PatternsAntineoplastic Agents, HormonalPlant ExtractsFenretinideMethylnitrosoureaTumor Cells, CulturedNeoplasm StagingBreast Neoplasms, MaleOrganoselenium CompoundsTeaDietMastectomyEarly Detection of CancerGenes, BRCA1Cell Transformation, NeoplasticTreatment OutcomeRetinoidsPolyphenolsAzasteroidsNeoplasm ProteinsPostmenopauseTime FactorsImmunohistochemistryAntioxidantsSelenium CompoundsEflornithineCyclooxygenase 2Chemotherapy, AdjuvantCarcinoma, LobularQuestionnairesUnited StatesProspective StudiesFinasterideRisk AssessmentThiocyanatesFollow-Up StudiesAzoxymethaneGenetic Predisposition to DiseaseAntimutagenic AgentsPyrazolesDose-Response Relationship, DrugSignal TransductionCarcinoma, Intraductal, NoninfiltratingColorectal NeoplasmsBreast FeedingMice, NudeCase-Control StudiesRiskKeratosisRetrospective StudiesSurvival AnalysisAntineoplastic Combined Chemotherapy ProtocolsPhytotherapyRNA, MessengerGarlicCarcinomaPremenopauseMCF-7 CellsEstrogensRandomized Controlled Trials as Topic